The relationship of sociodemographic and clinical characteristics with the length of stay of COVID-19 patients at Dr. R. Soedjono Hospital, Selong, East Lombok
DOI:
https://doi.org/10.53638/phpma.2022.v10.i1.p10Keywords:
COVID-19, pandemic, sociodemography, length of stayAbstract
Background and purpose: By December 2020, 678 confirmed cases of COVID-19 were recorded in East Lombok District, and more are anticipated. The capacity of the available healthcare institutions is now impacted by the inclusion of these cases. In this study, the duration of stay of COVID-19 patients at Dr. R. Soedjono Hospital in Selong, East Lombok will be described, as well as the association between sociodemographic and clinical factors with length of stay.
Methods: This is an observational study with a cross-sectional design using medical records of 409 patients who were confirmed positive for COVID-19 then treated in April-December 2020 and declared cured after completed the treatment period. The data collected included the date of admission and discharge of patients, age, gender, marital status, education, occupation, history of comorbidities and laboratory test results. Data analysis was performed using multiple logistic regression.
Results: The average length of stay for COVID-19 patients at Dr. R. Soedjono Hospital Selong, East Lombok was 16 days (SD±7,366) and the median was 14 days (IQR=7). Multivariate analysis shows factors for patients being treated for longer time (the average length of stay ≥17 days) were male (AOR=1.87; 95%CI: 1.21-2.86) and low education level (AOR=1.91; 95%CI: 1.19-3.06).
Conclusion: The average length of stay of COVID-19 patients in this hospital was quite long at 16 days. Male COVID-19 patients and those with low education have higher likelihood to stay longer in hospital. The hospital should consider this information to improve hospital planning for COVID-19 patients
References
Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely related? Clinical Microbiology and Infection. 2020; 26(6):729–734.
Mohammadi M, Meskini M, Lucia A. 2019 novel coronavirus (COVID-19) overview. Journal of Public Health. 2020; 19:1-9.
Ministry of Health of the Republic of Indonesia. Information on Emerging Infections Ministry of Health RI [Internet]. 2020 [updated May, 31th 2020; cited May, 31th 2020]. Available from: https://infeksiemerging.kemkes.go.id.
Faes C, Abrams S, Van Beckhoven D, Meyfroidt G, Vlieghe E, Hens N, et al. Time between symptom onset, hospitalisation and recovery or death: Statistical analysis of Belgian COVID-19 patients. International Journal of Environmental Research and Public Health. 2020; 17(20):1–18.
Yu P, Zhu J, Zhang Z, Han Y. A Familial Cluster of Infection Associated with the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period. J Infect Dis. 2020;221(11):1757-61.
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Int Med. 2020; 172:577-82.
Guo A, Lu J, Tan H, Kuang Z, Luo Y, Yang T, et al. Risk factors on admission associated with hospital length of stay in patients with COVID-19: a retrospective cohort study. Scientific Reports. 2021; 11(1): 1-7.
Zheng H, Tan J, Zhang X, Luo A, Wang L, Zhu W, et al. Impact of sex and age on respiratory support and length of hospital stay among 1792 patients with COVID-19 in Wuhan, China. British Journal of Anaesthesia. 2020; 125(4) :e378-e380.
Medical records of COVID-19 patients at RSUD Soedjono Selong East Lombok on 24 December 2020.
Li S, Lund JB, Christensen K, Baumbach J, Mengel-From J, Kruse T, et al. Exploratory analysis of age and sex dependent DNA methylation patterns on the X-chromosome in whole blood samples. Genome Medicine; 2020; 12(1).
Gao Y, Li T, Han M, Li X, Wu D, Xu Y, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19. Journal of Medical Virology. 2020; 92(7):791–796.
Sun D, Li H, Lu XX, Xiao H, Ren J, Zhang FR, et al. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study. World Journal of Pediatrics. 2020; 16(3):251–259.
Biswas R. Are men more vulnerable to COVID-19 as compared to women? Biomedical Journal of Scientific & Technical Research. 2020; 27(2): 20645–20646.
Strindhall J, Skog M, Ernerudh J, Bengner M, Löfgren S, Matussek A, et al. The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: The Swedish HEXA immune study. Age. 2013; 35(3):985–991.
Silva J, Lucas C, Sundaram M, Israelow B, Wong P, Klein J, et al. Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality. medRxiv [Preprint]. 2021. Available at: https://www.medrxiv.org/content/10.1101/2021.01.04.21249236v2.
Wulandari A, Rahman F, Pujianti N, Sari AR, Laily N, Anggraini L, et al. Relationship of individual characteristics with knowledge about prevention of coronavirus disease 2019 in communities in South Kalimantan. Jurnal Kesehatan Masyarakat Indonesia. 2020; 15(1): 42-46.
Prihantana AS, Wahyuningsih SS. Relationship between knowledge and adherence to treatment in tuberculosis patients at RSUD dr. Soehadi Prijonegoro Sragen. Farmasi Science and Practice. 2016; II(1).
Napirah MR, Rahman A, Tony A. Factors associated with health facility utilization in Tambarana Public Health Center in North Poso Pesisir District in Poso Regency. Journal of City Development. 2016; 4(1): 29-39.
Sastradimulya F, Nurhayati E, Susanti Y. Relationship between knowledge for National Health Insurance with BPJS membership status. Prosiding Research of UNISBA. 2015; 2.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Muhammad Junaedi , I Made Ady Wirawan, Kadek Tresna Adhi
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
**Creative Commons Attribution 4.0 International License (CC BY 4.0)**
*Welcome to the world of open collaboration and shared creativity! The Creative Commons Attribution 4.0 International License (CC BY 4.0) empowers creators to share their work with the world while maintaining certain rights.*
**Key Points:**
1. **Freedom to Share:** CC BY 4.0 allows creators to share their work globally, granting others the freedom to use, remix, and build upon it.
2. **Attribution Requirement:** Users can use the work for any purpose, even commercially, as long as they provide appropriate credit to the original creator.
3. **Flexibility:** Applicable to various content types—text, images, music, videos—the license fosters a diverse range of creations.
**Common Use Cases:**
- **Education:** Widely used for educational materials, promoting open learning environments.
- **Research:** Applied to scholarly articles, accelerating the dissemination of knowledge.
**How to Use:**
1. **Share:** Share your work with the world, marking it with the CC BY 4.0 license.
2. **Attribution:** Users, when utilizing the work, must provide proper attribution to honor the original creator.
**Conclusion:**
CC BY 4.0 contributes to a more open and collaborative digital landscape. Join the movement of shared knowledge and creativity!
*For full license details, visit [Creative Commons](https://creativecommons.org/licenses/by/4.0/).*
